Market Momentum Report: Sabra Healthcare REIT Inc (SBRA)’s Negative Close at 14.42

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $14.42 in the last session, down -1.23% from day before closing price of $14.60. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 1.06 million shares were traded. SBRA stock price reached its highest trading level at $14.655 during the session, while it also had its lowest trading level at $14.41.


We take a closer look at SBRA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.69. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.90.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on January 30, 2024, initiated with a Buy rating and assigned the stock a target price of $21.

On October 17, 2023, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $16.

Wells Fargo Upgraded its Underweight to Equal Weight on October 16, 2023, whereas the target price for the stock was revised from $13 to $15.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 22 ’24 when Cusack Catherine bought 7,000 shares for $14.43 per share. The transaction valued at 101,010 led to the insider holds 46,385 shares of the business.

FOSTER MICHAEL J sold 10,000 shares of SBRA for $146,830 on May 14 ’24. The Director now owns 63,923 shares after completing the transaction at $14.68 per share. On Sep 01 ’23, another insider, Costa Michael Lourenco, who serves as the Executive VP, CFO & Secretary of the company, bought 1,947 shares for $12.63 each. As a result, the insider paid 24,591 and bolstered with 183,218 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 3338172416 and an Enterprise Value of 5726912000. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 68.02, and their Forward P/E ratio for the next fiscal year is 22.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.04 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 8.807 whereas that against EBITDA is 14.539.

Stock Price History:

Over the past 52 weeks, SBRA has reached a high of $14.92, while it has fallen to a 52-week low of $11.06. The 50-Day Moving Average of the stock is 1.29%, while the 200-Day Moving Average is calculated to be 3.90%.

Shares Statistics:

According to the various share statistics, SBRA traded on average about 1.82M shares per day over the past 3-months and 1352320 shares per day over the past 10 days. A total of 231.27M shares are outstanding, with a floating share count of 227.99M. Insiders hold about 1.52% of the company’s shares, while institutions hold 93.85% stake in the company. Shares short for SBRA as of 1715731200 were 9718879 with a Short Ratio of 5.34, compared to 1713139200 on 11335505. Therefore, it implies a Short% of Shares Outstanding of 9718879 and a Short% of Float of 6.0500003.

Dividends & Splits

The forward annual dividend rate for SBRA is 1.20, which was 1.2 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.08219178The stock’s 5-year Average Dividend Yield is 9.04.

Earnings Estimates

Investors are keenly observing as 5.0 analysts analyze and rate the current performance of Sabra Healthcare REIT Inc (SBRA) in the stock market.On average, analysts expect EPS of $0.15 for the current quarter, with a high estimate of $0.15 and a low estimate of $0.14, while EPS last year was $0.09. The consensus estimate for the next quarter is $0.15, with high estimates of $0.16 and low estimates of $0.14.

Analysts are recommending an EPS of between $0.58 and $0.54 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $0.63, with 5.0 analysts recommending between $0.69 and $0.58.

Revenue Estimates

According to 7 analysts, the current quarter’s revenue is expected to be $166.21M. It ranges from a high estimate of $172.4M to a low estimate of $160.86M. As of the current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $161.17MFor the next quarter, 7 analysts are estimating revenue of $168.43M. There is a high estimate of $174.6M for the next quarter, whereas the lowest estimate is $162.4M.

A total of 6 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $691.1M, while the lowest revenue estimate was $644.9M, resulting in an average revenue estimate of $671.06M. In the same quarter a year ago, actual revenue was $647.52MBased on 7 analysts’ estimates, the company’s revenue will be $704.71M in the next fiscal year. The high estimate is $747.55M and the low estimate is $662.7M.

Most Popular